CNBM (03323) announced that, with approval from the China Securities Regulatory Commission (CSRC) under document [2025]1858, the company has been authorized to issue up to RMB 20 billion in corporate bonds to professional investors via phased offerings. The third series of its 2025 Sci-Tech Innovation Corporate Bonds, targeting professional investors, has a maximum issuance scale of RMB 3 billion.

This bond issuance comprises two tranches: Tranche 1 with a 3-year tenor and Tranche 2 with a 5-year tenor. The offering includes an inter-tranche reallocation option, allowing unlimited adjustment between tranches based on subscription demand, subject to agreement between the issuer and the bookrunner.

On November 11, 2025, the issuer and lead underwriters conducted an offline coupon rate inquiry with professional institutional investors. Following negotiations, Tranche 1 was not ultimately issued, while Tranche 2’s coupon rate was finalized at 1.95%.